Partner News
NanoString
March 10, 2024
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
February 24, 2024
European UPC Court of Appeal Overturns Injunction Impacting NanoString’s CosMx Products, Company to Immediately Resume Sales in 16 EU Countries
February 9, 2024
NanoString Announces Completion of Financing to Support Restructuring Process
February 4, 2024
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
January 7, 2024
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
January 1, 2024
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
Oxford Nanopore Technologies
March 11, 2024
Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use
February 26, 2024
Oxford Nanopore sequencing technology used to develop an assay for comprehensive variant analysis in spinal muscular atrophy (SMA)
January 30, 2024
Lonza and Oxford Nanopore to collaborate on novel test to accelerate analysis of mRNA products
January 22, 2024
Leadership Update: Welcoming Nick Keher as CFO; Tim Cowper takes COO role
PacBio
February 27, 2024
How do advancements in digital health technologies contribute to cancer care – including prevention, monitoring, and post-treatment support?
February 27, 2024
The Race For Answers: How Radboud University Medical Center Is Reducing The Time It Takes To Identify Rare Diseases
Recent Updates
- October 3, 2023
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab
- July 11, 2023
Next Level Genomics Pte Ltd Installs First PacBio Revio Sequencer in Singapore
- October 3, 2023
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab
- July 11, 2023
